Lipoprotein Lipase antibody (AA 300-327)
-
- Target See all Lipoprotein Lipase (LPL) Antibodies
- Lipoprotein Lipase (LPL)
-
Binding Specificity
- AA 300-327
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This Lipoprotein Lipase antibody is un-conjugated
-
Application
- Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- This LPL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 300-327 amino acids from the Central region of human LPL.
- Isotype
- Ig Fraction
- Top Product
- Discover our top product LPL Primary Antibody
-
-
- Application Notes
-
For FACS starting dilution is: 1:25
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:10~50 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
- Target
- Lipoprotein Lipase (LPL)
- Alternative Name
- LPL (LPL Products)
- Synonyms
- HDLCQ11 antibody, LIPD antibody, fb62e04 antibody, fc49b03 antibody, wu:fb62e04 antibody, wu:fc49b03 antibody, LPL antibody, lipd antibody, hdlcq11 antibody, lpl antibody, LOC100223817 antibody, lipoprotein lipase antibody, LPL antibody, Lpl antibody, lpl antibody
- Background
- LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq].
- Molecular Weight
- 53 kDa
- Gene ID
- 4023
- UniProt
- P06858
- Pathways
- Lipid Metabolism
-